Expertise in
11
conditions

Dr. Justin D. Roberts

Cardiology
217 Harrisburg Avenue, 
Lancaster, PA 
On Staff At
Accepting New Patients
Expertise in
11
conditions
217 Harrisburg Avenue, 
Lancaster, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Justin Roberts is a Cardiologist in Lancaster, Pennsylvania. Dr. Roberts is highly rated in 11 conditions, according to our data. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Pacemaker Implantation, and Cardiac Ablation. Dr. Roberts is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Des Moines College Of Osteopathic Medicine
Residency
Lehigh Valley Hospital and Health Network
Specialties
Cardiology
Licenses
Internal Medicine in PA
Board Certifications
Advanced Heart Failure And Transplant Cardiology, 2014
Cardiovascular Disease, 2012
Fellowships
Lehigh Valley Hospital and Health Network
University of Minnesota Hospitals
Hospital Affiliations
Lancaster General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

The Heart Group of Lancaster General Health
217 Harrisburg Avenue, Lancaster, PA 17603

Additional Areas of Focus

Dr. Roberts has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pulmonary Edema
Atrial Septal Defect (ASD)
Patent Foramen Ovale
Pulmonary Hypertension
Giant Cell Myocarditis
Cardiac Amyloidosis
Pulmonary Valve Stenosis
Cardiomyopathy
Arrhythmogenic Right Ventricular Cardiomyopathy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Enrollment Status: Unknown
Publish Date: January 23, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Enrollment Status: Terminated
Publish Date: June 23, 2017
Intervention Type: Device
Study Phase: Phase 3
View 6 Less Clinical Trials

5 Total Publications

Creation of root cause analysis and action (RCA2) standard work by a multidisciplinary team to prevent harm, reduce bias, and improve safety culture.
Creation of root cause analysis and action (RCA2) standard work by a multidisciplinary team to prevent harm, reduce bias, and improve safety culture.
Journal: Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Management
Published: August 21, 2024
Similar Doctors
Expertise in
20
conditions
Dr. Jeffrey S. Arkles
Cardiology
Expertise in
20
conditions
Dr. Jeffrey S. Arkles
Cardiology

The Heart Group Of Lancaster General Health

217 Harrisburg Avenue, 
Lancaster, PA 
 (0.1 miles away)
717-544-8300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Arkles is a Cardiologist in Lancaster, Pennsylvania. Dr. Arkles is highly rated in 20 conditions, according to our data. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation. Dr. Arkles is currently accepting new patients.

Expertise in
24
conditions
Dr. Francis E. Marchlinski
Cardiology
Expertise in
24
conditions
Dr. Francis E. Marchlinski
Cardiology

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
 (59.5 miles away)
215-615-4949
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Francis Marchlinski is a Cardiologist in Philadelphia, Pennsylvania. Dr. Marchlinski is highly rated in 24 conditions, according to our data. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation. Dr. Marchlinski is currently accepting new patients.

Expertise in
36
conditions
Dr. Saman Nazarian
Cardiology
Expertise in
36
conditions
Dr. Saman Nazarian
Cardiology

Penn Heart And Vascular Center Radnor

145 King Of Prussia Road, Suite 110, 
Center Radnor, PA 
 (48.0 miles away)
215-615-4949
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Saman Nazarian is a Cardiologist in Center Radnor, Pennsylvania. Dr. Nazarian is highly rated in 36 conditions, according to our data. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation. Dr. Nazarian is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roberts's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile